Developing a new framework for dose calculation

被引：18

作者：

Gurney, H ^{[1
]}

机构：

[1] Univ Sydney, Westmead Hosp, Dept Med Oncol, Westmead, NSW 2145, Australia

[2] Univ Sydney, Westmead Hosp, Dept Med, Westmead, NSW 2145, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 10期

关键词：

D O I：

10.1200/JCO.2005.05.1607

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1489 / 1490

页数：2

共 12 条

[1] Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests [J].

Andersson, T ;

Flockhart, DA ;

Goldstein, DB ;

Huang, SM ;

Kroetz, DL ;

Milos, PM ;

Ratain, MJ ;

Thummel, K .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) :559-581

[2] Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001 [J].

Baker, SD ;

Verweij, J ;

Rowinsky, EK ;

Donehower, RC ;

Schellens, JHM ;

Grochow, LB ;

Sparreboom, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (24) :1883-1888

[3] Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index [J].

Colleoni, M ;

Li, SG ;

Gelber, RD ;

Price, KN ;

Coates, AS ;

Castiglione-Gertsch, M ;

Goldhirsch, A .

LANCET, 2005, 366 (9491) :1108-1110

[4] Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure [J].

de Jongh, FE ;

Verweij, J ;

Loos, WJ ;

de Wit, R ;

de Jonge, MJA ;

Planting, AST ;

Nooter, K ;

Stoter, G ;

Sparreboom, A .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3733-3739

[5] Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials [J].

Di Maio, M ;

Gridelli, C ;

Gallo, C ;

Shepherd, F ;

Piantedosi, FV ;

Cigolari, S ;

Manzione, L ;

Illiano, A ;

Barbera, S ;

Robbiati, SF ;

Frontini, L ;

Piazza, E ;

Ianniello, GP ;

Veltri, E ;

Castiglione, F ;

Rosetti, F ;

Gebbia, V ;

Seymour, L ;

Chiodini, P ;

Perrone, F .

LANCET ONCOLOGY, 2005, 6 (09) :669-677

[6] Undertreatment of obese women receiving breast cancer chemotherapy [J].

Griggs, JJ ;

Sorbero, MES ;

Lyman, GH .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) :1267-1273

[7] I don't underdose my patients...do I? [J].

Gurney, H .

LANCET ONCOLOGY, 2005, 6 (09) :637-638

[8] Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative [J].

Gurney, H .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2590-2611

[9] How to calculate the dose of chemotherapy [J].

Gurney, H .

BRITISH JOURNAL OF CANCER, 2002, 86 (08) :1297-1302

[10] Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values [J].

Loos, WJ ;

de Jongh, FE ;

Sparreboom, A ;

de Wit, R ;

van Boven-van Zomeren, DM ;

Stoter, G ;

Nooter, K ;

Verweij, J .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (10) :1499-1506

← 1 2 →